Fangzheng Securities Research Report points out that the brand has both OTC products+brand+channels, and the leading effect is obvious. Against the backdrop of frequent medical reform policies, normalization of collection, and continued expansion of the OTC (OTC) market, branded OTC companies with steady performance, high dividend rates, and both product+brand+channel have high investment value. Recommended attention: China Resources 39, Taiji Group, Yunnan Baiyao, etc.
方正证券：品牌OTC产品+品牌+渠道兼具 龙头效应明显
Fangzheng Securities: Branded OTC products+brand+channels have an obvious leading effect
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.